RUA Life Sciences plc (AIM:RUA)
London · Delayed Price · Currency is GBP · Price in GBX 24.55
+0.55 (2.29%)
Jul 27, 2026, 2:10 PM GMT
RUA Life Sciences Market Cap
RUA Life Sciences has a market cap or net worth of 15.2 million as of July 27, 2026. Its market cap has increased by 108.51% in one year.
Market Cap
15.20M
Enterprise Value
13.53M
Revenue
4.62M
Ranking
n/a
PE Ratio
53.99
Stock Price
24.55
ChartMarket Cap Chart
Since February 26, 1997, RUA Life Sciences's market cap has decreased from 23.82M to 15.20M, a decrease of -36.17%. That is a compound annual growth rate of -1.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 15.20M | 75.00% |
| Dec 31, 2025 | 8.69M | 27.27% |
| Dec 31, 2024 | 6.83M | 11.68% |
| Dec 29, 2023 | 6.11M | -43.19% |
| Dec 30, 2022 | 10.76M | -35.33% |
| Dec 31, 2021 | 16.64M | -50.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 199.90B |
| GSK plc | 78.10B |
| Haleon | 32.61B |
| Smith & Nephew | 9.77B |
| genedrive | 16.86M |
| Inspiration Healthcare Group | 16.59M |
| Aptamer Group | 15.55M |
| Cambridge Cognition Holdings | 15.13M |